Differential effects of chlorpromazine on secretion, protein phosphorylation and phosphoinositide metabolism in stimulated platelets
- 15 August 1986
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 238 (1) , 159-166
- https://doi.org/10.1042/bj2380159
Abstract
1. Increasing concentrations of chlorpromazine (30-500 .mu.M) caused a progressive lysis of gel-filtered platelets, as monitored by the extracellular appearance of cytoplasmic ([14C]adenine-labelled) adenine nucleotides. The chlorpromazine-induced lysis was markedly enhanced by thrombin and phorbol ester, and complete cytolysis was found at chlorpromazine concentrations of 100 .mu.M and above in the presence of thrombin. 2. At non-lytic concentrations, chlorpromazine caused a dramatic increase in the thrombin- or phorbol ester-mediated incorporation of 32P into phosphatidylinositol 4-phosphate and, to a lesser extent, into phosphatidylinositol 4,5-bisphosphate in platelets pulse-labelled with [32P]Pi. Chlorpromazine alone also caused an incorporation of 32P into the phosphoinositides. 3. Non-lytic concentrations of chlorpromazine had no effect on the phosphorylation of the 47 kDa protein (regarded as the substrate for protein kinase C), but markedly inhibited the accompanying secretion of ATP+ADP and .beta.-hexosaminidase when platelets were incubated with 0.17 .mu.M-phorbol ester or 0.1-0.2 unit of thrombin/ml. At lower concentrations of thrombin, chlorpromazine did not inhibit, but slightly enhanced, secretion. 4. A protein of 82 kDa was phosphorylated during the interaction of platelets with thrombin and phorbol ester, and this phosphorylation was enhanced by chlorpromazine (non-lytic). 5. These results suggest that the previously reported inhibition of protein kinase C by chlorpromazine is probably non-specific and due to cytolysis. However, since non-lytic concentrations of chlorpromazine inhibit secretion, but not protein kinase C, in platelets, activation of protein kinase C is not involved in the stimulation-secretion coupling, or chlorpromazine acts at a step after kinase activation. Possible mechanisms of this inhibition by chlorpromazine are discussed in the light of its effect on phosphoinositide metabolism and protein phosphorylation.This publication has 38 references indexed in Scilit:
- Cationic amphiphilic drugs perturb the metabolism of inosititides and phosphatidic acid in photoreceptor membranesBiochemical and Biophysical Research Communications, 1986
- Tumour‐promoting phorbol esters inhibit agonist‐induced phosphatidate formation and Ca2+ flux in human plateletsFEBS Letters, 1985
- Phorbol myristate acetate stimulates formation of phosphatidyl inositol 4-phosphate and phosphatidyl inositol 4,5-bisphosphate in human plateletsBiochemical and Biophysical Research Communications, 1984
- 1-Oleoyl-2-acetyl-glycerol (OAG) stimulates the formation of phosphatydylinositol 4-phosphate in intact human plateletsBiochemical and Biophysical Research Communications, 1984
- 12‐O‐Tetradecanoylphorbol 13‐acetate stimulates inositol lipid phosphorylation in intact human plateletsFEBS Letters, 1984
- Modulation of Ca2+-activated, phospholipid-dependent protein kinase in platelets treated with a tumor-promoting phorbol esterBiochemical and Biophysical Research Communications, 1984
- Trifluoperazine and chlorpromazine block secretion from human platelets evoked at basal cytoplasmic free calcium by activators of C‐kinaseFEBS Letters, 1983
- The rapid polyphosphoinositide metabolism may be a triggering event for thrombin-mediated stimulation of human plateletsBiochemical and Biophysical Research Communications, 1983
- Phospholipid turnover as a possible transmembrane signal for protein phosphorylation during human platelet activation by thrombinBiochemical and Biophysical Research Communications, 1980
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970